TONIX PHARMACEUTICALS HOLDIN (TNXP)

US8902608541 - Common Stock

0.16  0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
7.77M0.000.000.000.00
Cost Of Goods
4.74MN/AN/AN/AN/A
Gross Profit
3.03MN/AN/AN/AN/A
Operating Expenses
121.41M112.09M92.31M50.51M28.83M
Research and Development
86.66M81.88M68.84M36.16M18.19M
Selling, General, and Administrative Expenses
34.75M30.22M23.47M14.35M10.64M
Operating Income
-118.38M-112.09M-92.31M-50.51M-28.83M
Interest Income/Expense
N/A1.87M30.00K50.00K210.00K
Other Income/Expense
1.72MN/AN/AN/AN/A
Income Before Taxes
-116.66M-110.22M-92.29M-50.46M-28.62M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-116.66M-116.88M-92.29M-52.17M-31.09M
EBITDA
-114.09M-110.84M-92.26M-50.48M-28.80M
 
Per Share Data
EPS Diluted Total Ops
-6.85-20.44-51.27-111.00-3.11K
Non GAAP EPS
-8.62-25.44-8.32-23.04-990.40
 
Statistics
Gross Profit Margin
38.97%N/AN/AN/AN/A
Profit Margin
-1501.78%N/AN/AN/AN/A
Operating Profit Margin
-1523.94%N/AN/AN/AN/A

All data in USD

Charts